Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Puma Biotechnology, Inc.

NASDAQ: PBYI · Life Sciences · 5 alerts · CIK 1401667

Share price
$7.34Close, Nov 16
Market cap
$379M
Shares outstanding
51.7MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Puma Biotechnology, Inc. filings on SEC EDGAR ↗

4:34 PM ET 10-Q
Financial Results

Puma Biotechnology Q3 2026 Results: Net Income $5.96M, Down 32.7% YoY

Puma Biotechnology reported total revenue of $55.1 million for the third quarter of 2026, driven primarily by NERLYNX product sales. While the company remained profitable with a net income of $6.0 million, this was a decrease from $8.8 million in the prior year's third quarter due to higher research and development expenses.

Key figure
Net income $5.96M · -32.7% YoY
4:17 PM ET 8-K
Financial Results

Puma Biotechnology Financial Results

Puma Biotechnology reported Q3 2026 financial results with total product revenue of $54.1 million, driven by sales of NERLYNX. The company reported GAAP net income of $6.0 million and raised its full-year 2026 net income guidance while continuing to advance its alisertib clinical development programs.

Term
Q3 2026

“Third quarter U.S. NERLYNX sales were positively impacted by increased year-over-year demand and were negatively impacted by higher than expected gross to net due to an increase in Medicaid and 340B sales, as well as a delay in sales to Puma’s ex-U.S. commercial partners that shifted from the third quarter to the fourth quarter.”

Alan H. Auerbach, Chairman, Chief Executive Officer and President

“We continue to anticipate increased year-over-year demand for NERLYNX, while we continue to advance alisertib across our ALISCA® clinical development programs.”

Alan H. Auerbach, Chairman, Chief Executive Officer and President

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.